The “Goldilocks” zone: A key to cellular adaptability and resilience

In a discovery that could redefine how we understand cellular resilience and adaptability, scientists at Scripps Research have unlocked the secret interactions between a primordial inorganic polymer of phosphate known as polyphosphate (polyP), and two basic building blocks of life: DNA and the element magnesium.

CinRx touts positive early-stage data from two obesity candidates

CinFina Pharma, a subsidiary of the hub-and-spoke biotech CinRx, shared early-stage data for two of its Janssen-licensed obesity candidates at this year’s ObesityWeek. CIN-110, a

November 4, 2024

MWC Barcelona 2025: Huawei unveils global showcases alongside customers and launches 10 industry solutions with partners – Pharmaceutical Technology

In collaboration with global customers across various industries, Huawei unveiled 83 global showcases at MWC Barcelona 2025. Together with its industry customers, Huawei unveiled 83

March 4, 2025

Mainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for Employees – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 19.12.2023 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

December 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.